uniQure (QURE) Current Deferred Revenue (2015 - 2020)
uniQure (QURE) posted quarterly Current Deferred Revenue of $2.1 million for Q4 2020, down 72.7% year-over-year from $7.6 million in Q1 2020, and down 72.84% quarter-over-quarter from $7.7 million in Q3 2020.
uniQure (QURE) Current Deferred Revenue (2015 - 2020) Analysis & Trends
uniQure's Current Deferred Revenue history runs 6 years deep, the most recent figure standing at $2.1 million for Q4 2020.
- In Q4 2020, Current Deferred Revenue fell 72.7% year-over-year to $2.1 million; the TTM figure through Dec 2020 stood at $2.1 million (down 72.7% YoY), while the FY2020 annual figure was $2.1 million, down 72.7% from the prior year.
- Current Deferred Revenue for Q4 2020 stood at $2.1 million, down from $7.7 million in the prior quarter.
- The five-year high for Current Deferred Revenue was $9.7 million in Q1 2018, with the low at $2.1 million in Q4 2020.
- The 5-year median for Current Deferred Revenue is $7.2 million (2019), against an average of $6.7 million.
- The sharpest annual moves came in 2018 and 2020: Current Deferred Revenue jumped 102.26% in 2018, then tumbled 72.7% in 2020.
- uniQure's Current Deferred Revenue stood at $6.1 million in 2016, then retreated by 24.89% to $4.6 million in 2017, then jumped by 65.49% to $7.6 million in 2018, then fell by 0.09% to $7.6 million in 2019, then sank by 72.7% to $2.1 million in 2020.
- Business Quant data shows QURE's Current Deferred Revenue at $2.1 million in Q4 2020, $7.7 million in Q3 2020, and $6.2 million in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | uniQure | 3.37 Bn | 3.37 Bn | 5.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 2.08 Mn |
| Sep 30, 2020 | 7.67 Mn |
| Jun 30, 2020 | 6.15 Mn |
| Mar 31, 2020 | 6.73 Mn |
| Dec 31, 2019 | 7.63 Mn |
| Sep 30, 2019 | 7.53 Mn |
| Jun 30, 2019 | 7.22 Mn |
| Mar 31, 2019 | 7.77 Mn |
| Dec 31, 2018 | 7.63 Mn |
| Sep 30, 2018 | 8.59 Mn |
| Jun 30, 2018 | 8.46 Mn |
| Mar 31, 2018 | 9.70 Mn |
| Dec 31, 2017 | 4.61 Mn |
| Sep 30, 2017 | 4.25 Mn |
| Jun 30, 2017 | 5.20 Mn |
| Mar 31, 2017 | 6.23 Mn |
| Dec 31, 2016 | 6.14 Mn |
| Dec 31, 2015 | 6.78 Mn |